论文部分内容阅读
目的观察地尔硫治疗扩张型心肌病的临床疗效及预后。方法将50例确诊为扩张型心肌病的患者随机分为治疗组和对照组。治疗组26例,对照组24组,两组患者均常规抗心衰、抗凝药物治疗,治疗组26例加服地尔硫30mg每日2次8个月后复查超声心动图、X线胸片。结果地尔硫使扩张型心肌病心功能改善,超声心动图显示左室舒张末期内径缩小,左室射血分数升高,心胸比例缩小,病死率降低。结论长期应用地尔硫治疗扩张型心肌病可改善心功能,提高生活质量,改善预后。
Objective To observe the clinical efficacy and prognosis of diltiazem in the treatment of dilated cardiomyopathy. Methods Fifty patients diagnosed as dilated cardiomyopathy were randomly divided into treatment group and control group. 26 cases in the treatment group and 24 cases in the control group. The patients in both groups were given routine anti-heart failure and anticoagulant therapy. Twenty-six patients in the treatment group were treated with Diltiazem 30mg twice daily for 8 months and then examined by echocardiography, sheet. Results Diltiazem improved cardiac function in patients with dilated cardiomyopathy. Echocardiography showed that left ventricular end-diastolic diameter decreased, left ventricular ejection fraction increased, heart-thorax decreased, and mortality decreased. Conclusion Long-term use of diltiazem in the treatment of dilated cardiomyopathy can improve cardiac function, improve quality of life and improve prognosis.